Literature DB >> 3207206

Yield of stool cultures, ova and parasite tests, and Clostridium difficile determinations in nosocomial diarrheas.

B Yannelli1, I Gurevich, P E Schoch, B A Cunha.   

Abstract

Stool cultures for bacterial pathogens, ova and parasites, and Clostridium difficile are usually ordered for patients with nosocomial diarrhea. In the interest of cost containment we undertook an 18-month retrospective study to assess the cost/benefit of performing each of these three tests. During the study period nosocomial diarrhea developed in 118 patients. Of 452 bacterial stool cultures ordered, only one was positive for Campylobacter jejuni and none for ova and parasites. However, of 126 cultures examined for C. difficile, 47 showed positive results. We conclude that bacterial stool culture and ova and parasite identification are not indicated for patients with nosocomial diarrhea. Elimination of these unnecessary stool tests (bacterial/ova and parasite) would have saved the hospital approximately +7530 in the 18-month study period.

Entities:  

Mesh:

Year:  1988        PMID: 3207206     DOI: 10.1016/s0196-6553(88)80003-8

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  15 in total

1.  Selective criteria for the microbiological examination of faecal specimens.

Authors:  R A Bowman; J M Bowman; S A Arrow; T V Riley
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

2.  Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.

Authors:  S P Sambol; M M Merrigan; D Lyerly; D N Gerding; S Johnson
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Value of routine stool cultures in hospitalized patients with diarrhea.

Authors:  F Barbut; P Leluan; G Antoniotti; A Collignon; A Sédallian; J C Petit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

4.  Cost and time savings following introduction of rejection criteria for clinical specimens.

Authors:  A J Morris; L K Smith; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

Review 5.  The economic impact of Clostridium difficile infection: a systematic review.

Authors:  Natasha Nanwa; Tetyana Kendzerska; Murray Krahn; Jeffrey C Kwong; Nick Daneman; William Witteman; Nicole Mittmann; Suzanne M Cadarette; Laura Rosella; Beate Sander
Journal:  Am J Gastroenterol       Date:  2015-04-07       Impact factor: 10.864

Review 6.  Laboratory diagnosis of bacterial gastroenteritis.

Authors:  Romney M Humphries; Andrea J Linscott
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

7.  Differential yield of pathogens from stool testing of nosocomial versus community-acquired paediatric diarrhea.

Authors:  S Deorari; A McConnell; K K Tan; N Jadavji; D Ma; D Church; G Katzko; D G Gall; T Jadavji; H D Davies
Journal:  Can J Infect Dis       Date:  1999-11

8.  Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea.

Authors:  S S Johal; C P Lambert; J Hammond; P D James; S P Borriello; Y R Mahida
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

9.  N-CDAD in Canada: results of the Canadian Nosocomial Infection Surveillance Program 1997 N-CDAD Prevalence Surveillance Project.

Authors:  M Hyland; M Ofner-Agostini; M Miller; S Paton; M Gourdeau; M Ishak
Journal:  Can J Infect Dis       Date:  2001-03

10.  Contemporary testing for enteric pathogens: the potential for cost, time, and health care savings.

Authors:  A J Morris; P R Murray; L B Reller
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.